Hum. Reprod. Advance Access published online on July 31, 2006
Human Reproduction, doi:10.1093/humrep/del297
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Centre de Recherche, Hôpital Saint-François d’Assise, Centre Hospitalier Universitaire de Québec, Canada
* To whom correspondence should be addressed. BACKGROUND: Endometriosis is a disease where endometrial tissue implants in ectopic locations. Remodelling of the extracellular matrix (ECM) is a prerequisite for the implantation of this tissue to be possible. METHODS: In this study, we detected immunoreactive matrix metalloproteinase-9 (MMP-9) throughout endometrial tissue and identified von Willebrand factor (vWF)-positive endothelial cells, CD45-positive leukocytes, CD3-positive T lymphocytes and CD68-positive macrophages as cells expressing MMP-9 in the stroma. RESULTS: We found an increased expression of MMP-9 in the uterine endometrial tissue of women with endometriosis, as assessed by zymography and enzyme-linked immunosorbent assay (ELISA) (P < 0.05). However, RT-PCR did not show a statistically significant increase in MMP-9 mRNA expression in these tissues (P = 0.14). There was no significant difference between women with and without endometriosis in the expression of tissue inhibitor of MMPs (TIMP)-1, a known natural inhibitor of the pro- and active forms of MMP-9, whether tested by ELISA or by RT-PCR (P = 0.46 and 0.37, respectively). Interestingly, the ratio of MMP-9/TIMP-1 expression was significantly higher in women with endometriosis than in normal women both at the protein and the mRNA levels (P < 0.05). CONCLUSION: These findings make plausible the involvement of MMP-9/TIMP-1 imbalance in the invasiveness of the endometrial tissue of patients with endometriosis and the ectopic development of the disease.
Received February 2, 2006
Revised June 13, 2006
Accepted June 23, 2006
Article
Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis
T. Collette 1, R. Maheux 2, J. Mailloux 3, and A. Akoum 2 *
2 Centre de Recherche, Hôpital Saint-François d’Assise, Centre Hospitalier Universitaire de Québec; Département d’Obstétrique et Gynécologie, Faculté de Médecine, Université Laval, Québec, Canada
3 Département d’Obstétrique et Gynécologie, Faculté de Médecine, Université Laval, Québec, Canada
A. Akoum, E-mail: ali.akoum{at}crsfa.ulaval.ca
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Yu, Y. Wang, W.-H. Zhou, L. Wang, Y.-Y. He, and D.-J. Li Combination of estrogen and dioxin is involved in the pathogenesis of endometriosis by promoting chemokine secretion and invasion of endometrial stromal cells Hum. Reprod., July 1, 2008; 23(7): 1614 - 1626. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.C. Ferreira, C.A. Witz, L.S. Hammes, N. Kirma, F. Petraglia, R.S. Schenken, and F.M. Reis Activin A increases invasiveness of endometrial cells in an in vitro model of human peritoneum Mol. Hum. Reprod., May 1, 2008; 14(5): 301 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Guay and A Akoum Stable inhibition of interleukin 1 receptor type II in Ishikawa cells augments secretion of matrix metalloproteinases: possible role in endometriosis pathophysiology Reproduction, September 1, 2007; 134(3): 525 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Florio, F. M. Reis, P. B. Torres, F. Calonaci, P. Toti, C. Bocchi, E. A. Linton, and F. Petraglia Plasma Urocortin Levels in the Diagnosis of Ovarian Endometriosis Obstet. Gynecol., September 1, 2007; 110(3): 594 - 600. [Abstract] [Full Text] [PDF] |
||||



